Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
|
|
Cadrenal Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| MURPHY JOHN RAYMOND (Director) has filed a Form 4 on Cadrenal Therapeutics, Inc.|
Txns:
| Bought 17,331 shares
@ $0.7, valued at
$12.1k
Bought 2,669 shares
@ $0.69, valued at
$1.8k
|
|
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2023 |
4
| MURPHY JOHN RAYMOND (Director) has filed a Form 4 on Cadrenal Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $1.39, valued at
$13.9k
|
|
| 03/16/2023 |
4
| MURPHY JOHN RAYMOND (Director) has filed a Form 4 on Cadrenal Therapeutics, Inc.|
Txns:
| Bought 20,000 shares
@ $1.6699, valued at
$33.4k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2023 |
4
| WILSON GLYNN (Director) has filed a Form 4 on Cadrenal Therapeutics, Inc.|
Txns:
| Converted 50,000 shares
@ $0
Converted 50,000 convertible notes
@ $1, valued at
$50k
|
|
| 01/24/2023 |
4
| Szot Matthew K (CFO) has filed a Form 4 on Cadrenal Therapeutics, Inc.|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 01/24/2023 |
4
| MURPHY JOHN RAYMOND (Director) has filed a Form 4 on Cadrenal Therapeutics, Inc.|
Txns:
| Converted 514,792 shares
@ $0
Converted 514,792 convertible notes
@ $1, valued at
$514.8k
|
|
|
|